Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | -0.74% | 178.19 | 0.7% | $1350.94m | |
| MRK | Merck & Co., Inc. | 0.21% | 92.61 | 0.7% | $1211.55m | |
| PFE | Pfizer Inc. | -1.20% | 51.68 | 0.9% | $1096.02m | |
| LLY | Eli Lilly & Co. | 0.74% | 327.13 | 1.1% | $1026.00m | |
| BMY | Bristol-Myers Squibb Co. | -1.13% | 75.97 | 1.0% | $991.64m | |
| ABBV | AbbVie, Inc. | 0.03% | 153.85 | 1.9% | $959.73m | |
| AZN | AstraZeneca Plc | -0.67% | 65.51 | 1.0% | $470.96m | |
| SGEN | Seagen Inc. | -1.85% | 176.77 | 5.7% | $326.06m | |
| GSK | GSK Plc | -1.01% | 43.31 | 0.2% | $272.45m | |
| TPTX | Turning Point Therapeutics, Inc. | 0.05% | 75.15 | 0.0% | $199.28m | |
| HZNP | Horizon Therapeutics Plc | 2.38% | 82.76 | 5.4% | $174.09m | |
| NVS | Novartis AG | -0.11% | 84.27 | 0.2% | $172.25m | |
| MRTX | Mirati Therapeutics, Inc. | 1.10% | 71.96 | 1.6% | $150.81m | |
| ALNY | Alnylam Pharmaceuticals, Inc. | 1.67% | 150.73 | 8.1% | $150.31m | |
| NVO | Novo Nordisk A/S | -0.40% | 111.19 | 0.1% | $148.30m |
Company Profile
PDS Biotechnology Corp. engages in the development of clinical-stage immunotherapies to treat various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products PDS0101, is an off the shelf immunotherapeutic that is administered by subcutaneous injection. The company was founded by Frank K. Bedu-Addo on March 15, 2019 and is headquartered in Princeton, NJ.